CONDENSED VERSION.. For those that don't want to read my

New Post Public Reply Private Reply Replies (1) Message Board
martymech
371
CONDENSED VERSION.. For those that don't want to read my novel. lol

http://capwhale.com/newsfile/details/20230418...2172.shtml


The EGOC consolidated shares were completed, taking a further step forward for the proposed transfer

Whales
2023-04-18 18:50:01
SHANGHAI, April 2023, 4 /PRNewswire/ -- On March 18, 2023, Energy 3 Corp (stock code: EGOC), a U.S.-listed company with global innovative agriculture, health and new energy as its core business, has been reviewed by the Financial Industry Regulatory Authority and officially completed the merger of EGOC common stock. The total number of common shares of the Company will be 30,1,52 after the completion of the share merger, which will optimize the Company's shareholder base and prepare for the positive conversion After the common shares of EGOC Corporation, the total number of common shares issued has been reduced, and the stock price after the merger will increase in proportion. Pooling shares to reduce the number of common shares and increase the corresponding share price of the company's common stock. Except as disclosed above, the Company will not issue any new common shares.

EGOC's share price for the active conversion of common shares has also changed accordingly, and the closing price as of April 2023, 4 US time has increased by 10.37%. After the EGOC merger of shares, the proportion of investors' transaction costs has been significantly reduced, and the narrowing of bid-ask spreads is conducive to stock trading, stimulating active stock trading volume and liquidity, and bringing a larger investor base and higher share trading flow. It will also help attract more international institutional participants and increase liquidity, enhance the market image of EGOC and enhance the long-term interests of the company's shareholders.

EGOC has been sparing no effort to make breakthroughs in the development of modern agriculture and biological health, and after the completion of this joint venture, it will be injected into the Group's high-quality assets, which will help promote the Group's business development and increase shareholder returns, which is a major milestone for the Company's proposed transfer of the board, which is a further step for the proposed transfer.

After the completion of this share merger, EGOC intends to inject high-quality business assets into the company's entity, implement unified financial data conversion U.S GAAP statements, and prepare a data basis for actively recommending the transfer of the board. The enterprise entity has always implemented the development policy of industrialized operation, deeply cultivated and refined in the field of modern agriculture and biological health, upgraded the industry to systematic and refined, and combined with the upstream and downstream resources of the industry to achieve a win-win situation between scientific and technological research and development transformation and corporate profit generation. EGOC intends to inject high-quality business assets into the company's main body, such as cross-border intelligent e-commerce, biotechnology, ecological black pig and other mature projects, in addition to the global sustainable development of new energy project upgrades, join hands with strong resources to enter Xinjiang new energy wind power, photovoltaic fields, and continue to increase new profit impetus for the company's next stage of development.

EGOC combines the current situation of the group's industrial chain, adheres to the requirements of the US securities authorities as a reference, and realizes the transfer with higher requirements of profit, stock price and market value after injecting high-quality business assets, and has made calculations and plans for the second and third stages of technology and industrial development of the enterprise in advance, and returns the company's global shareholders and upstream and downstream customers with the steady development of the enterprise.

As an innovative technology-based enterprise, EGOC is deeply engaged in the field of modern agricultural health and new energy industry, and is committed to providing green and healthy products for all customers and potential customers with the world's most advanced scientific and technological research and development, and continues to provide healthy and differentiated service products for all user groups in the past.

Forward-Looking Statements

Certain statements in this press release are forward-looking statements, including, but not limited to, the Company's proposed offering. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company's current expectations and projections regarding future events that the Company believes could affect its financial condition, results of operations, business strategy and financial needs, including expectations that the Offering will be successfully completed. Investors can use expressions such as "approximate", "evaluate", "believe", "hope", "expect", "estimate", "project", "intend", "plan", "will", "should", "could", "may" or similar expressions. The Company undertakes no obligation to publicly update or revise any forward-looking statements to reflect subsequent events or circumstances, or to change in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will prove to be correct, and the Company cautions investors that actual results may differ materially from the expected results and encourages investors to review other factors that could affect its future results in the Company's registration statement and other filings with the Securities and Exchange Commission.

Contact:
Man Kong Lam
+852-9126-7205
richardlam@g2gcpa.com

The articles reproduced on the Ziwhale website are only for the purpose of disseminating information, sharing, exchange and learning, and are not for commercial purposes, and their copyrights belong to the original author; Where the information appearing on this website, for reference only, this website will try its best to ensure the integrity of the reprinted information, if the original author has any questions about the reprinted articles on this website, please contact this website in time, this website will actively protect the legitimate rights and interests of the copyright owner.
++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
http://capwhale.com/newsfile/details/20230418...2172.shtml
HAPPY HUNTING FOR THOSE CHEAP SHARES OF EGOC THIS COMING WEEK!

Energy 1 Corporation (EGOC) Stock Research Links

EGOC Board Company Profile Buy Rating Time & Sales News Filings Financials
What I post is my opinions and thoughts based on my research. Please do your own DD before buying or selling any stock. I am just as capable as the next guy in making good or bad investment choices! We win a few, we lose a few. That is the nature of the game!
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 5

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 1

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 0

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 5

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 1

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 0

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 2

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 1

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 7

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 8

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading

Top 5 Most Recently Viewed Articles

Cofactor Genomics Appoints New CEO to Enhance Patient Access

Updated Category News Views 169

Cofactor Genomics Appoints Chris Parker as New CEO Cofactor Genomics, Inc., a commercial-stage company dedicated to bridging the precision medicine gap through RNA decoding, has announced a significant leadership transition. Chris Parker has been appointed as the new CEO and Board Member, succeeding Jarret Glasscock, who will continue his contributions in the roles of...

Continue Reading
Minto Apartment REIT Declares Cash Distribution for July 2025

Updated Category News Views 168

Minto Apartment REIT's Cash Distribution Announcement Minto Apartment Real Estate Investment Trust (MI) has recently made an important announcement regarding its cash distribution. The REIT has declared a monthly cash distribution of $0.04333 per unit for the month of July 2025. This translates to an annualized rate of $0.52 per unit. The payment is set to be distributed...

Continue Reading
National Geographic–Lindblad Expands Alaska Offerings for Travelers

Updated Category News Views 89

Expanding Exploration: National Geographic–Lindblad's New Chapter in Alaska National Geographic–Lindblad Expeditions is celebrating a significant milestone in its quest to enhance adventure travel in Alaska, with plans to expand its offerings starting in 2027. The company is known for its pioneering spirit and leadership in expedition travel, and this expansion is a...

Continue Reading
Brian Krause Takes the Helm as Chief Development Officer at Panera

Updated Category News Views 453

Brian Krause Appointed as Chief Development Officer at Panera Bread Panera Bread, a leader in the fast casual dining sector, has recently announced the appointment of Brian Krause as its new Chief Development Officer. With a wealth of experience in franchise development and strategic growth, Krause aims to propel the company's expansion plans. Krause's Experience and...

Continue Reading
Strategic Growth Ahead for Blockmate Ventures with New Funding

Updated Category News Views 115

Blockmate Ventures Expands Its Horizons with New Investment Blockmate Ventures Inc. (TSX.V: MATE), a company recognized for its innovative approach in the tech world, has recently announced a significant investment commitment of CAD $1,400,000. This strategic funding comes from a group of investors, featuring notable industry figure Antanas Guoga, popularly known as Tony...

Continue Reading